nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR7—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0768	0.0768	CbGpPWpGaD
Molindone—ADRA2A—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.0641	0.0641	CbGpPWpGaD
Molindone—HTR1A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0569	0.0569	CbGpPWpGaD
Molindone—DRD2—Amine ligand-binding receptors—TAAR6—cervical cancer	0.05	0.05	CbGpPWpGaD
Molindone—HTR2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0491	0.0491	CbGpPWpGaD
Molindone—CHRM1—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0489	0.0489	CbGpPWpGaD
Molindone—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—STAT3—cervical cancer	0.0471	0.0471	CbGpPWpGaD
Molindone—ADRA2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0447	0.0447	CbGpPWpGaD
Molindone—HTR7—G alpha (s) signalling events—TAAR6—cervical cancer	0.0317	0.0317	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.0175	0.0175	CbGpPWpGaD
Molindone—HTR7—Circadian rythm related genes—UBE3A—cervical cancer	0.0165	0.0165	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.0153	0.0153	CbGpPWpGaD
Molindone—HTR7—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0151	0.0151	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—TAAR6—cervical cancer	0.0115	0.0115	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0112	0.0112	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—UBE3A—cervical cancer	0.0108	0.0108	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—UBE3A—cervical cancer	0.0105	0.0105	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00983	0.00983	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00967	0.00967	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00962	0.00962	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—SERPIND1—cervical cancer	0.00904	0.00904	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—GP6—cervical cancer	0.00904	0.00904	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—WNT2—cervical cancer	0.00898	0.00898	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0088	0.0088	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—TAAR6—cervical cancer	0.00852	0.00852	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—GP5—cervical cancer	0.0079	0.0079	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—TAAR6—cervical cancer	0.00748	0.00748	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—TAAR6—cervical cancer	0.00736	0.00736	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—TAAR6—cervical cancer	0.00732	0.00732	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—WNT5A—cervical cancer	0.0068	0.0068	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—TAAR6—cervical cancer	0.0067	0.0067	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—WNT2—cervical cancer	0.00665	0.00665	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00665	0.00665	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—TAAR6—cervical cancer	0.0065	0.0065	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—TAAR6—cervical cancer	0.0059	0.0059	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—WNT2—cervical cancer	0.00584	0.00584	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—WNT2—cervical cancer	0.00575	0.00575	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00575	0.00575	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—WNT2—cervical cancer	0.00572	0.00572	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—WNT2—cervical cancer	0.00523	0.00523	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—WNT5A—cervical cancer	0.00504	0.00504	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.00482	0.00482	CbGpPWpGaD
Molindone—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.00477	0.00477	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—WNT2—cervical cancer	0.00461	0.00461	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—AKAP13—cervical cancer	0.00445	0.00445	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—WNT5A—cervical cancer	0.00443	0.00443	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—TAAR6—cervical cancer	0.00437	0.00437	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—WNT5A—cervical cancer	0.00436	0.00436	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—WNT5A—cervical cancer	0.00433	0.00433	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—TAAR6—cervical cancer	0.00423	0.00423	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—TAAR6—cervical cancer	0.00416	0.00416	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—TAAR6—cervical cancer	0.00414	0.00414	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—AKAP13—cervical cancer	0.00404	0.00404	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—WNT5A—cervical cancer	0.00396	0.00396	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—TAAR6—cervical cancer	0.00384	0.00384	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—TAAR6—cervical cancer	0.00378	0.00378	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	0.00378	0.00378	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—TAAR6—cervical cancer	0.00376	0.00376	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—WNT5A—cervical cancer	0.00349	0.00349	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TAAR6—cervical cancer	0.00349	0.00349	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00346	0.00346	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—TAAR6—cervical cancer	0.00344	0.00344	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—WNT2—cervical cancer	0.00341	0.00341	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00334	0.00334	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.0033	0.0033	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—WNT2—cervical cancer	0.003	0.003	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKAP13—cervical cancer	0.003	0.003	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00299	0.00299	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.00295	0.00295	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—WNT2—cervical cancer	0.00293	0.00293	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.0029	0.0029	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00288	0.00288	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.00285	0.00285	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKAP13—cervical cancer	0.00284	0.00284	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—WNT2—cervical cancer	0.00272	0.00272	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	0.00268	0.00268	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.00263	0.00263	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.00259	0.00259	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.00259	0.00259	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.00259	0.00259	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.00258	0.00258	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKAP13—cervical cancer	0.00258	0.00258	CbGpPWpGaD
Molindone—HTR7—Circadian rythm related genes—TP53—cervical cancer	0.00244	0.00244	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKAP13—cervical cancer	0.00239	0.00239	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.00236	0.00236	CbGpPWpGaD
Molindone—CHRM1—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.00236	0.00236	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.00227	0.00227	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.00227	0.00227	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.00224	0.00224	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.00223	0.00223	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—WNT5A—cervical cancer	0.00222	0.00222	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TAAR6—cervical cancer	0.00222	0.00222	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—WNT5A—cervical cancer	0.00206	0.00206	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.00203	0.00203	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.00203	0.00203	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.00202	0.00202	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—CA9—cervical cancer	0.00179	0.00179	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—WNT2—cervical cancer	0.00177	0.00177	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.00177	0.00177	CbGpPWpGaD
Molindone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00177	0.00177	CbGpPWpGaD
Molindone—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00176	0.00176	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.00174	0.00174	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—WNT2—cervical cancer	0.00173	0.00173	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00159	0.00159	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.00159	0.00159	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—TP53—cervical cancer	0.00156	0.00156	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.00155	0.00155	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.00153	0.00153	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.00153	0.00153	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKAP13—cervical cancer	0.00152	0.00152	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NOTCH2—cervical cancer	0.00145	0.00145	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.00139	0.00139	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.00134	0.00134	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.00132	0.00132	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—WNT5A—cervical cancer	0.00131	0.00131	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.0012	0.0012	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HES1—cervical cancer	0.00119	0.00119	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.00107	0.00107	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TERT—cervical cancer	0.00104	0.00104	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—FGFR3—cervical cancer	0.000954	0.000954	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000942	0.000942	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000927	0.000927	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000922	0.000922	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NOTCH1—cervical cancer	0.000896	0.000896	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HES1—cervical cancer	0.00088	0.00088	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000843	0.000843	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—EGFR—cervical cancer	0.000798	0.000798	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HES1—cervical cancer	0.000772	0.000772	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000771	0.000771	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HES1—cervical cancer	0.00076	0.00076	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HES1—cervical cancer	0.000756	0.000756	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000726	0.000726	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000707	0.000707	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000691	0.000691	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—TP53—cervical cancer	0.00068	0.00068	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TERT—cervical cancer	0.000677	0.000677	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MTOR—cervical cancer	0.000671	0.000671	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000666	0.000666	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000664	0.000664	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TERT—cervical cancer	0.000662	0.000662	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000621	0.000621	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CASP3—cervical cancer	0.000618	0.000618	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000611	0.000611	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FGFR3—cervical cancer	0.000608	0.000608	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000606	0.000606	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CTNNB1—cervical cancer	0.000595	0.000595	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000592	0.000592	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000583	0.000583	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000574	0.000574	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	0.000571	0.000571	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000556	0.000556	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000522	0.000522	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000519	0.000519	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—STAT3—cervical cancer	0.000519	0.000519	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000511	0.000511	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—EGFR—cervical cancer	0.000508	0.000508	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MTOR—cervical cancer	0.000498	0.000498	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EGFR—cervical cancer	0.000472	0.000472	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	0.000465	0.000465	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—cervical cancer	0.000458	0.000458	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	0.000441	0.000441	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MTOR—cervical cancer	0.000437	0.000437	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MTOR—cervical cancer	0.00043	0.00043	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MTOR—cervical cancer	0.000428	0.000428	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—cervical cancer	0.000402	0.000402	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TP53—cervical cancer	0.000396	0.000396	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—cervical cancer	0.000395	0.000395	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—cervical cancer	0.000393	0.000393	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MTOR—cervical cancer	0.000391	0.000391	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CTNNB1—cervical cancer	0.000387	0.000387	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—STAT3—cervical cancer	0.000385	0.000385	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	0.000381	0.000381	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	0.000379	0.000379	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—cervical cancer	0.00036	0.00036	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EGFR—cervical cancer	0.000349	0.000349	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	0.000347	0.000347	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—STAT3—cervical cancer	0.000338	0.000338	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—STAT3—cervical cancer	0.000332	0.000332	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—STAT3—cervical cancer	0.00033	0.00033	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGFR—cervical cancer	0.000307	0.000307	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—STAT3—cervical cancer	0.000302	0.000302	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGFR—cervical cancer	0.000302	0.000302	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGFR—cervical cancer	0.0003	0.0003	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TP53—cervical cancer	0.000293	0.000293	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGFR—cervical cancer	0.000275	0.000275	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TP53—cervical cancer	0.000258	0.000258	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TP53—cervical cancer	0.000253	0.000253	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TP53—cervical cancer	0.000252	0.000252	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TP53—cervical cancer	0.000231	0.000231	CbGpPWpGaD
